View as an RSS Feed
View Jason Tillberg's Articles BY TICKER:
- Amazon and American Oriental Bioengineering: How to Benefit From Inefficient Share Prices
- Recovery in Personal Income Has Yet to Begin
- This Small-Cap Chinese Drugmaker Is Fund Manager Jason Tillberg's Highest Conviction Pick
- American Oriental Bioengineering - A Value Investment
- Short Amazon: Risky Investment at Current Price
- Hain Celestial Group: Buy, Sell or Hold?
- Starbucks: Highly Overvalued in a Mightily Overbought Market
- Dow Target 6,617, October 25, 2009: Here Is Why
- Value Investing Metrics Suggests Bear Market Resumption Soon
- High End Home Market Still Has Further to Fall
- Covered Call Strategy with American Oriental BioEngineering
- Why Amazon Is Overvalued
- Bed Bath and Beyond Still Appears Expensive
- In the Bargain Bin: American Oriental Bioengineering
- What's It Going to Be: Inflation or Deflation?
- Negative Real Rates of Return Should Force Investors into Precious Metals
- Premier Exhibitions: Good Business, Good Buy
- Negative on Real Estate, Retail and Financials
- Time To Be Fearful?
- Starbucks: Price is What You Pay, Value is What You Get